Lockheed lands Pentagon deal for 850 F-35 jets, lifts annual forecast

Lockheed Martin agreed to a 10-year framework to sell the Pentagon at least 850 F-35s, worth at least $78 billion, while committing at least $7 billion to support production and repair capacity; the agreement is not a sales order and requires congressional approval. The company raised its 2026 sales forecast to $80 billion–$82 billion, EPS forecast to $30.35–$30.75, and free-cash-flow forecast to $7.8 billion–$8 billion. Quarterly sales rose 11% to $20.71 billion and EPS was $7.97 versus a $7.43 estimate; backlog reached a record $292 billion, and shares surged as much as 10%.

Analysis

The market is treating the F-35 framework as durable demand, but it is not yet a sales order: congressional approval and conversion into funded annual awards remain key gates. That distinction matters after a sharp share-price re-rating. The more investable signal is the combination of funded missile demand and improved cash-flow guidance, not the headline value of the 10-year framework.

The capacity constraint is shifting from aircraft assembly alone to repair throughput and supplier labor/tooling. Dedicated repair lines could reduce competition between maintenance and new-part production, supporting fleet availability and future sustainment revenue; near term, however, Lockheed’s self-funded investment and higher capacity spending add execution and cash-conversion risk. If suppliers cannot staff or qualify the added lines, the production target may not translate into deliveries on schedule.

The broader defense demand backdrop supports RTX and Northrop Grumman as well, but the article’s stronger direct evidence for Lockheed is its funded PAC-3 award and F-35 exposure. Avoid extrapolating this framework to peers’ earnings. Over 1–3 months, watch congressional action, funded awards, delivery cadence, and whether free cash flow meets the raised range. Over 6–18 months, repair capacity and supplier throughput determine whether backlog converts to revenue and cash. A reversal in geopolitical urgency, procurement delays, or cost escalation could unwind the premium. Contrarian point: the headline backlog is not equivalent to near-term revenue, and the already-large share reaction leaves less room for an unqualified upside surprise.

Key Decisions for Investors

• Do not chase LMT after the sharp repricing. Consider adding on a pullback only if congressional approval and subsequent funded awards preserve the F-35 path; the upside case is backlog conversion plus sustained missile demand, while the downside is framework slippage and weaker cash conversion.
• Use quarterly free cash flow, aircraft deliveries, and supplier/repair-line progress as confirmation. Reassess the long thesis if LMT falls short of its raised 2026 free-cash-flow range or cannot sustain the stated production cadence.
• Keep RTX and NOC as sector beneficiaries rather than assuming they share Lockheed’s F-35 economics. Compare their order growth and cash conversion before taking a relative-value position; the article alone does not establish a compelling pair trade.
• Track congressional approval and funded procurement actions as near-term catalysts. If approval is delayed or awards are materially below the framework, treat the headline contract value as an unreliable earnings indicator.